Comprehensive Overview of Sitagliptin for the Pharmacist: Clinical Insights and Evidence-Based Guidance

1. Introduction to Sitagliptin Sitagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor, marketed under the brand name Januvia® (and as Janumet® in combination with metformin). It is a cornerstone therapy in…

Continue ReadingComprehensive Overview of Sitagliptin for the Pharmacist: Clinical Insights and Evidence-Based Guidance